SKI Market

Indian Indices

Sensex

80,238.85 -1,048.34
( -1.29%)

Global Indices

Nasdaq

48,844.08 -676.12
(-1.37%)

Dow Jones

6,870.91 -58.95
(-0.85%)

Hang Seng

56,282.78 -1,774.46
(-3.06%)

Nikkei 225

10,782.87 -127.68
(-1.17%)

Forex

USD-INR

91.06 0.13
(0.14%)

EUR-INR

107.55 0.22
(0.20%)

GBP-INR

122.70 -0.27
(-0.22%)

JPY-INR

0.58 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Consolidated Construction Consortium Ltd

Industry : Construction

BSE Code

ISIN Demat

Book Value()

532902

INE429I01024

6.1390641

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CCCL

40.18

682.2

EPS(TTM)

Face Value()

Div & Yield %

0.38

Back

Nectar Lifescience consolidated net profit rises 82.02% in the December 2025 quarter

Jan 24,2026

Net profit of Nectar Lifescience rose 82.02% to Rs 14.27 crore in the quarter ended December 2025 as against Rs 7.84 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.

80,238.85 -1,048.34 ( -1.29%)

48,844.08 -676.12 (-1.37%)

6,870.91 -58.95 (-0.85%)

56,282.78 -1,774.46 (-3.06%)

10,782.87 -127.68 (-1.17%)

91.06 0.13 (0.14%)

107.55 0.22 (0.20%)

122.70 -0.27 (-0.22%)

0.58 0.00 (0.12%)